Omalizumab rapidly decreases nasal allergic response and FcεRI on basophilsHenry C. Lin, Thomas B. Casale, Barbara A. Foster et al.|Journal of Allergy and Clinical Immunology|2004Cited by 267
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitisPaul Chervinsky, Howard Fox, Thomas B. Casale et al.|Annals of Allergy Asthma & Immunology|2003Cited by 214